A5054933261- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Pancreatitis Pathology and Treatment
- Liver Diseases and Immunity
- Inflammatory Bowel Disease
- Microscopic Colitis
- Eosinophilic Esophagitis
- Inflammatory mediators and NSAID effects
- Alcohol Consumption and Health Effects
- Gastroesophageal reflux and treatments
- Diverticular Disease and Complications
- COVID-19 Clinical Research Studies
- Esophageal and GI Pathology
- Hemoglobinopathies and Related Disorders
- Gallbladder and Bile Duct Disorders
- Gastric Cancer Management and Outcomes
- Nutrition and Health in Aging
- Organ Transplantation Techniques and Outcomes
- Cancer, Lipids, and Metabolism
- Pediatric Hepatobiliary Diseases and Treatments
- Pancreatic and Hepatic Oncology Research
- Clostridium difficile and Clostridium perfringens research
- Helicobacter pylori-related gastroenterology studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Celiac Disease Research and Management
Liver Institute Northwest
2022-2025
Creighton University
2024-2025
California State University, Fresno
2020-2024
University of California, San Francisco
2020-2024
GTx (United States)
2024
University of Arizona
2022-2023
Maulana Azad Medical College
2023
Dayanand Medical College & Hospital
2022-2023
Ark Medical Center
2023
Punjab Institute of Medical Sciences
2022-2023
The third leading preventable cause of death in the United States is excessive alcohol consumption. Our study sought to assess impact coronavirus disease 2019 (COVID-19) on hospitalizations for alcohol-related hepatitis at a community hospital system. We hypothesized an increase cases requiring inpatient management, mirroring strain economic and societal norms imposed by COVID-19 pandemic.We performed retrospective chart review incidence patients presenting 3 hospitals Fresno, California,...
Tirzepatide is the first dual incretin glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor activator approved for management of type II diabetes mellitus. This drug was also recently by Food and Drug Administration as a option patients with obesity. has been reported to be beneficial in reducing liver fat content. Although its efficacy well described literature, no cases tirzepatide-induced hepatotoxicity have reported. We report case 37-year-old woman metabolic...
Objectives The study aimed to compare the risk of gastrointestinal infections among patients with and without metabolic dysfunction-associated fatty liver disease (MAFLD). Methods This was a population-based, retrospective, observational using data from National Inpatient Sample (NIS), largest all-payer US inpatient care database. Setting Hospitalisation adults aged ≥18 years old admitted in 2020 identified NIS. Patients were stratified by presence absence MAFLD. Participants 26.4 million...
Abstract INTRODUCTION Crohn’s disease (CD) poses clinical challenges characterized by unpredictable symptom exacerbations and remission periods. Biologic therapies like risankizumab offer promising strategies for managing CD. This study aims to comprehensively evaluate the efficacy of in achieving across diverse studies involving CD patients. METHODS A systematic search prominent databases, including PubMed, Embase, Cochrane Central Register Controlled Trials, was conducted identify relevant...
Clostridioides difficile infection (CDI) is the leading cause of hospital acquired-infectious diarrhea in USA. In this study, we assess prevalence and impact CDI COVID-19 hospitalizations USA.We used 2020 National Inpatient Sample database to identify adult patients with COVID-19. The were stratified into two groups based on presence CDI. outcomes such as in-hospital mortality, ICU admission, shock, acute kidney injury (AKI), sepsis rates. Multivariate regression analysis was performed...
Esophageal variceal bleeding is a common reason for hospitalization in patients with cirrhosis. The main objective of this study was to analyze the effects gender differences on outcomes hospitalizations related United States.A retrospective observational cohort performed using National Inpatient Sample (NIS) database all discharge diagnosis esophageal varices hemorrhage from 2016 2019. primary outcome in-hospital mortality, while secondary included rate early endoscopy (defined as less than...
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease associated with inflammation, fibrosis, and destruction of intra- extrahepatic bile ducts. Despite substantial recent advances in our understanding PSC, the only proven treatment PSC transplantation. There an urgent unmet need to find medical therapies for this disorder.
The concept of frailty has gained importance, especially in patients with liver disease. Our study systematically investigated the effect on post-procedural outcomes undergoing transjugular intrahepatic portosystemic shunt (TIPS).We used National Inpatient Sample(NIS) 2016-2019 data to identify who underwent TIPS. Hospital risk score (HFRS) was classify as frail (HFRS>=5) and non-frail (HFRS<5). relationship between such death, shock, non-home discharge, length stay (LOS), LOS, total...
Background: Despite the use of new immunotherapies, hepatocellular carcinoma (HCC) has a poor survival rate. Through multiple molecular mechanisms, aspirin (ASA) demonstrated reduced incidence HCC, however, impact long-term ASA on in-hospital outcomes not been studied. Methods: We queried National Inpatient Sample (NIS) database from 2016 to 2020 identify patients with HCC. Patients were stratified into two groups, based use. Information was collected regarding patient demographics,...
Patients with end-stage liver disease (ESLD) have a poor quality of life, which often worsens as severity increases. Palliative care (PC) has emerged management option in ESLD patients, especially for those who are not candidates transplant.
Abstract: The use of herbal and dietary supplements is rising in the United States. Turmeric has been one most popular recently, used widely for various conditions such as arthritis, digestive disorder, liver conditions. Although rarely reported, hepatotoxicity can happen with turmeric use. Here, we present 2 cases drug-induced injury due to complete resolution after cessation. Keywords: turmeric, DILI,